Adamas Pharmaceuticals Inc 4
4 · Adamas Pharmaceuticals Inc · Filed Feb 27, 2015
Insider Transaction Report
Form 4
Knapp Jeffrey H
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2015-02-25+65,000→ 65,000 totalExercise: $17.31Exp: 2025-02-24→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]The Option shares shall vest as follows: 1/48th of the option shares shall vest on the 1st of each month beginning with March 1, 2015, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of each such date.